Chairman Know Our Chairman Mr. Richard Prins has been our Chairman and Audit Committee Chairman since 2012, and has served as a Director since May 2007. Mr. Prins has more than 27 years of experience in private equity investing and investment banking and 14 years as a Director of a fully integrated specialty pharmaceutical company...
IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Data
Alzheimer’s Disease- Cannabis Formulation Shows Promise
Scientific IGC’s CEO and Key Advisor Quoted in “HIGH TIMES” Article on THC and Alzheimer’s Disease
IGC Builds Team Adding Industry Leader Dr. Chuanhai Cao, an expert on THC-Based Alzheimer’s Disease Treatments